Akums Drugs and Pharmaceutical (AKUMS)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 1,019.11 1,033.09 1,010.41 1,055.55 1,024.03 1,017.53 1,159.59 1,157.87
YOY Revenue Growth % - - - - 0.48% -1.51% 14.76% 9.69%
Other Income 6.55 13.47 14.56 17.55 26.73 32.37 34.33 35.30
Total Income 1,025.66 1,046.56 1,024.97 1,073.09 1,050.76 1,049.90 1,193.92 1,193.17
Total Expenses + 854.59 821.62 851.25 1,006.17 955.12 984.22 1,076.12 1,070.16
Cost of Materials Consumed 559.50 505.67 564.60 623.85 547.90 552.63 611.26 586.91
Employee Benefit Expense 176.22 180.10 175.60 183.90 176.14 189.27 189.38 199.03
Other Expenses 118.87 135.85 111.06 138.65 137.00 141.22 144.77 146.65
Operating Profit 164.52 211.47 159.16 49.37 68.92 33.31 83.47 87.71
OPM % 16.1% 20.5% 15.8% 4.7% 6.7% 3.3% 7.2% 7.6%
Profit Before Tax + 87.48 91.59 91.05 75.14 95.65 65.67 99.57 121.22
Tax Expense 26.27 24.94 24.74 -74.47 30.96 22.98 31.89 39.87
Tax % 30% 27.2% 27.2% -99.1% 32.4% 35% 32% 32.9%
Profit After Tax 61.21 66.65 66.31 149.61 64.69 42.70 67.67 81.34
EPS (Basic) 4.21 4.37 4.26 9.64 4.15 2.66 4.33 5.53

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 4,118.16
YOY Revenue Growth % -
Other Income 52.12
Total Income 4,170.28
Total Expenses + 3,841.72
Cost of Materials Consumed 2,253.61
Employee Benefit Expense 715.82
Other Expenses 504.42
Operating Profit 276.43
OPM % 6.7%
Profit Before Exceptional 328.56
Exceptional Items 16.70
Profit Before Tax + 345.25
Tax Expense 1.48
Tax % 0.4%
Profit After Tax 343.78
EPS (Basic) 22.60

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 1,838.83
Property, Plant & Equipment 1,390.18
Capital Work in Progress 159.62
Non-Current Investments 0.14
Goodwill 2.06
Other Intangible Assets 5.13
Current Assets + 2,274.61
Inventories 680.93
Trade Receivables 770.30
Cash and Cash Equivalents 101.19
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 30.62
Other Equity 3,016.39
Non-Current Liabilities 156.08
Current Liabilities 893.75
Total Liabilities 1,049.83

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities 465.20
Cash from Investing Activities -547.84
Cash from Financing Activities 72.79
Net Increase/Decrease in Cash -9.86